• Molecular NameFlurandrenolide
  • SynonymFloudroxycortide; Fludrossicortide [DCIT]; Fludroxicortida [INN-Spanish]; Fludroxicortidum; Fludroxycortide; Fludroxycortidum [INN-Latin]; Fluorandrenolone; Fluorandrenolone acetonide; Flurandrenolone; Flurandrenolone acetonide
  • Weight436.52
  • Drugbank_IDDB00846
  • ACS_NO1524-88-5
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.49
  • pkaN/A
  • LogD (pH=7, predicted)2.49
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-3.81
  • LogSw (predicted, AB/LogsW2.0)0.04
  • Sw (mg/ml) (predicted, ACD/Labs)0.07
  • No.of HBond Donors2
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA93.06
  • StatusFDA approved
  • AdministrationCutaneous
  • PharmacologyA synthetic steroid and is used as an anti-inflammatory treatment for use on skin irritations.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySystemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary- adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients
  • LD50 (rat)N/A
  • LD50 (mouse)N/A